Cargando…
Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals
This study aims to evaluate the potential role of pillboxes used for the preparation and delivery of individual daily medical treatments in the drug circuit of the Military Instruction Hospital (France) as reservoirs of bacterial contaminants. Samples were obtained from 32 pillboxes after decontamin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843434/ https://www.ncbi.nlm.nih.gov/pubmed/31614938 http://dx.doi.org/10.3390/ijerph16203878 |
_version_ | 1783468214511992832 |
---|---|
author | Dussart, Claude Boulliat, Caroline Camal, Isabelle Bourgeois, Denis Carrouel, Florence |
author_facet | Dussart, Claude Boulliat, Caroline Camal, Isabelle Bourgeois, Denis Carrouel, Florence |
author_sort | Dussart, Claude |
collection | PubMed |
description | This study aims to evaluate the potential role of pillboxes used for the preparation and delivery of individual daily medical treatments in the drug circuit of the Military Instruction Hospital (France) as reservoirs of bacterial contaminants. Samples were obtained from 32 pillboxes after decontamination (T1), after preparation in the pharmacy (T2), after use in two different medical units (T3), and again after usual mechanical washing (T4). Qualitative (identification and antibiotic susceptibility) and quantitative (contamination rate and number of colony forming units—CFUs) bacteriological tests were performed. Susceptible and resistant strains of environmental saprophytes were identified. The pillbox contamination rate was relatively low at T1 (13%). It was significantly increased at T2 (63%, p = 0.001 vs. T1), again at T3 (88%, p < 0.05 vs. T2, p < 0.001 vs. T1), and finally decreased dramatically at T4 (31%, p < 0.001 vs. T3, p > 0.05 vs. T1). The number of CFUs was significantly increased at T2 compared with that of T1 (36.7 ± 13.4 and 5.36 ± 3.64, respectively, p < 0.001) and again at T3 (84.4 ± 19.4, p < 0.001 vs. T1 and T2) and was significantly reduced at T4 (7.0 ± 2.0 vs. T3, p < 0.001) to a level that was not significantly different from that at T1. So, the use of pillboxes to deliver individual medications to patients in the hospital is a potential risk factor for bacterial cross-contamination. |
format | Online Article Text |
id | pubmed-6843434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68434342019-11-25 Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals Dussart, Claude Boulliat, Caroline Camal, Isabelle Bourgeois, Denis Carrouel, Florence Int J Environ Res Public Health Article This study aims to evaluate the potential role of pillboxes used for the preparation and delivery of individual daily medical treatments in the drug circuit of the Military Instruction Hospital (France) as reservoirs of bacterial contaminants. Samples were obtained from 32 pillboxes after decontamination (T1), after preparation in the pharmacy (T2), after use in two different medical units (T3), and again after usual mechanical washing (T4). Qualitative (identification and antibiotic susceptibility) and quantitative (contamination rate and number of colony forming units—CFUs) bacteriological tests were performed. Susceptible and resistant strains of environmental saprophytes were identified. The pillbox contamination rate was relatively low at T1 (13%). It was significantly increased at T2 (63%, p = 0.001 vs. T1), again at T3 (88%, p < 0.05 vs. T2, p < 0.001 vs. T1), and finally decreased dramatically at T4 (31%, p < 0.001 vs. T3, p > 0.05 vs. T1). The number of CFUs was significantly increased at T2 compared with that of T1 (36.7 ± 13.4 and 5.36 ± 3.64, respectively, p < 0.001) and again at T3 (84.4 ± 19.4, p < 0.001 vs. T1 and T2) and was significantly reduced at T4 (7.0 ± 2.0 vs. T3, p < 0.001) to a level that was not significantly different from that at T1. So, the use of pillboxes to deliver individual medications to patients in the hospital is a potential risk factor for bacterial cross-contamination. MDPI 2019-10-13 2019-10 /pmc/articles/PMC6843434/ /pubmed/31614938 http://dx.doi.org/10.3390/ijerph16203878 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dussart, Claude Boulliat, Caroline Camal, Isabelle Bourgeois, Denis Carrouel, Florence Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title | Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title_full | Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title_fullStr | Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title_full_unstemmed | Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title_short | Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals |
title_sort | safety evaluation of individual pillboxes to control cross-contamination in the drug circuit in hospitals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843434/ https://www.ncbi.nlm.nih.gov/pubmed/31614938 http://dx.doi.org/10.3390/ijerph16203878 |
work_keys_str_mv | AT dussartclaude safetyevaluationofindividualpillboxestocontrolcrosscontaminationinthedrugcircuitinhospitals AT boulliatcaroline safetyevaluationofindividualpillboxestocontrolcrosscontaminationinthedrugcircuitinhospitals AT camalisabelle safetyevaluationofindividualpillboxestocontrolcrosscontaminationinthedrugcircuitinhospitals AT bourgeoisdenis safetyevaluationofindividualpillboxestocontrolcrosscontaminationinthedrugcircuitinhospitals AT carrouelflorence safetyevaluationofindividualpillboxestocontrolcrosscontaminationinthedrugcircuitinhospitals |